quantisnow
FeedTopReportsPricing
⌘K
Live feed
10:52:32·798d
PRRelease
Pressure BioSciences, Inc. logo

Pressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing

PBIO· Pressure BioSciences, Inc.
Original source

Companies

  • PBIO
    Pressure BioSciences, Inc.
    n/a

Related

  • SEC440d
    SEC Form 10-Q filed by Pressure BioSciences, Inc.
  • INSIDER570d
    Director Peterson Jeffrey N acquired $1,670 worth of shares (59,652 units at $0.03), increasing direct ownership by 72% to 142,084 units (SEC Form 4)
  • INSIDER570d
    Director Urdea Michael S acquired $404 worth of shares (14,429 units at $0.03), increasing direct ownership by 44% to 47,588 units (SEC Form 4)
  • INSIDER570d
    President, CEO Schumacher Richard T acquired $641 worth of shares (22,878 units at $0.03), increasing direct ownership by 38% to 82,967 units (SEC Form 4)
  • INSIDER570d
    Director Lazarev Alexander V acquired $528 worth of shares (18,863 units at $0.03), increasing direct ownership by 102% to 37,400 units (SEC Form 4)
  • SEC594d
    SEC Form 10-Q filed by Pressure BioSciences, Inc.
  • SEC612d
    SEC Form NT 10-Q filed by Pressure BioSciences, Inc.
  • SEC645d
    Pressure BioSciences, Inc. filed SEC Form 8-K: Other Events
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022